Editorial overview: Antivirals and resistance: Advances and challenges ahead
- 1 October 2014
- journal article
- Published by Elsevier in Current Opinion in Virology
- Vol. 8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Resistance to nucleotide analogue inhibitors of hepatitis C virus NS5B: mechanisms and clinical relevanceCurrent Opinion in Virology, 2014
- Resistance to HIV integrase strand transfer inhibitors: in vitro findings and clinical consequencesCurrent Opinion in Virology, 2014
- Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistanceCurrent Opinion in Virology, 2014
- Antiviral drugs specific for coronaviruses in preclinical developmentCurrent Opinion in Virology, 2014
- Molecular basis of interferon resistance in hepatitis C virusCurrent Opinion in Virology, 2014
- The epidemiology and spread of drug resistant human influenza virusesCurrent Opinion in Virology, 2014
- Hepatitis C NS5A protein: two drug targets within the same protein with different mechanisms of resistanceCurrent Opinion in Virology, 2014
- Resistance to hepatitis C virus protease inhibitorsCurrent Opinion in Virology, 2014
- Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistanceCurrent Opinion in Virology, 2014
- Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistanceCurrent Opinion in Virology, 2014